Condition
Ambulatory Difficulty
Total Trials
3
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Withdrawn1
Recruiting1
Active Not Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07073235Not ApplicableRecruiting
Effects of Intermittent Theta Burst Stimulation (iTBS) on Motor Recovery of Lower Extremity in Chronic Stroke Patients
NCT05736484Not ApplicableActive Not Recruiting
Randomized Clinical Trial to Improve Mobility After Hospitalization
NCT03944473Phase 4WithdrawnPrimary
Efficacy and Safety of Sugammadex in High-Risk Ambulatory Surgeries
Showing all 3 trials